Medpace Holdings, Inc.(MEDP)

Sector:

Healthcare

Description:

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

Current Price

$212.06

RSI

75.73

Market Capitalization:

5.5B

Beta:

1.479

Volume:

315,514

Analyst Target Price:

$ 152.5

Economiic Fair Price:


February 13, 2023
October 25, 2022
Q3
N/A
N/A
N/A
N/A
N/A
31M
278.9M
4.81
15.90 %
31.86
0.207

25.54 %
32.94 %
27.72 %
29.83 %
49.61 %
124.32 %

$ 1.1B
23.38 %
$ 925.9M
7.54 %
$ 861M
22.19 %
$ 704.6M
61.55 %
$ 436.2M
3.46 %
$ 421.6M

$ 235.1M
3.40 %
$ 227.3M
23.58 %
$ 184M
30.87 %
$ 140.6M
65.19 %
$ 85.1M
8.82 %
$ 78.2M

$ 201.9M
19.77 %
$ 168.5M
35.01 %
$ 124.8M
32.87 %
$ 94M
64.99 %
$ 56.9M
159.35 %
$ 22M

News

Press Releases

Notable Dates